* A Phase II Multi-Center Study of SM-88 in Subjects With Pancreatic Cancer
Condition: Pancreatic Cancer Intervention: Drug: Combination of metyrosine-derivative with low-dose sirolimus, phenytoin and methoxsalen Sponsor: Tyme, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2018 Category: Research Source Type: clinical trials